baber/WOPTO huggingface dataset:
Patent BR-PI1101322-B1 (BR)
Title: Composições farmacêuticas antifúngicas contendo extratos e/ou óleo essencial de schinus terebinthifolius
Inventor: JACQUELINE APARECIDA TAKAHASHI
IPC: A61P31/10
Filed: 2011-03-04
Abstract: composições farmacêuticas antifúngicas contendo extratos e/ou óleo essencial de schinus tereb/nthifolius. a invenção descreve composições farmacêuticas antifúngicas contendo extrato e/ou óleo essencial puro dos frutos de schinus terebinthifolius, isolados ou associados/incluídos em ciclodextrinas. os antifúngicos atualmente disponíveis apresentam diversas limitações tais como, resistência microbiana, citotoxicidade, além de estarem associados a recidivas das doenças e diversos efeitos adversos ao paciente. portanto, o número crescente de infecções fúngicas e as limitações apresentadas pelos fármacos já existentes, tornam a busca por novos agentes antifúngicos um importante alicerce no incremento do arsenal terapêutico. as composições farmacêuticas da presente invenção podem ser utilizadas no tratamento de infecções fúngicas causadas por espécies de malassezia, em especial de m.furfur, sendo apresentadas nas formas sólida, semi- sólida ou líquida.
Patent BR-PI1105112-B1 (BR)
Title: dispositivo para a eliminação de vibrações de torção
Inventor: WOLFGANG BURKHARDT
IPC: F16F15/12
Filed: 2011-09-22
Abstract: DISPOSITIVO PARA A ELIMINAÇÃO DE VIBRAÇÕES DE TORÇÃO. A presente invenção refere-se ao dispositivo para a eliminação de vibrações de torção em sistemas propulsores, especialmente de motores de combustão no qual em um componente construído que gira com o sistema propulsor, está previsto ao menos um elemento de eliminação de vibrações, o qual para a conformação adaptada a ordem, apresenta uma guia integrada em um circuito giratório de eliminação definido, contendo uma massa de eliminação e sendo esta guia retentora da massa de eliminação com capacidade vibratória. De uma maneira especialmente simples do ponto de vista de construção e de técnica de acabamento, a massa de eliminação (2; 7) está unida com o componente construído (1; 6; 10) apenas através de um elemento de torção (3), fixo no componente construído ou através de um elemento de mola elástica (9), integrado no componente construído.
Patent CH-717779-B1 (CH)
Title: Hydromechanische Hybridgetriebeeinrichtung, bei der eine Leistungsverzweigung und eine Leistungssummierung miteinander kombiniert sind.
Inventor: LONG CHEN
IPC: F16H47/04
Filed: 2020-08-04
Abstract: Die vorliegende Erfindung stellt eine hydromechanische Hybridgetriebeeinrichtung, bei der eine Leistungsverzweigung und eine Leistungssummierung miteinander kombiniert sind, bereit. Sie umfasst eine Eingangswelle (1), einen Leistungsverzweigungsmechanismus (3), einen mechanischen Getriebemechanismus (4), einen Leistungssummierungsmechanismus (5), eine Ausgangswelle (6), einen hydraulischen Getriebemechanismus (7), eine Kupplungsbaugruppe (C1-C6) und eine Bremsenbaugruppe (B 1 -B 3 ), wobei die Eingangswelle (1) mit dem Leistungsverzweigungsmechanismus (3) verbindbar und der Leistungssummierungsmechanismus (5) mit der Ausgangswelle (6) verbindbar ist, wobei die Kupplungsbaugruppe (C1-C6) jeweils ein Ausgangsende des Leistungsverzweigungsmechanismus mit einem Eingangsende des mechanischen Getriebemechanismus (4) und einem Eingangsende des hydraulischen Getriebemechanismus (7) und jeweils ein Eingangsende des Leistungssummierungsmechanismus (5) mit einem Ausgangsende des mechanischen Getriebemechanismus (4) und einem Ausgangsende des hydraulischen Getriebemechanismus (7) verbinden kann, und wobei die Kupplungsbaugruppe (C1-C6) und die Bremsenbaugruppe (B 1 -B 3 ) so einstellbar sind, dass mittels des hydraulischen Getriebemechanismus (7) ein stufenloses Übersetzungsverhältnis zwischen der Eingangswelle (1) und der Ausgangswelle (6) bereitstellbar ist. Die vorliegende Erfindung stellt eine hydromechanische Multimode-Hybridgetriebeeinrichtung bereit, in die ein hydraulisches Getriebe, ein mittels des Leistungsverzweigungsmechanismus (3) bereitstellbares hydromechanisches Getriebe, ein mittels des Leistungssummierungsmechanismus (5) bereitstellbares Getriebe und ein mechanisches Getriebe integriert sind, womit die Anforderungen bei anspruchsvollem Betrieb mit mehreren Betriebszuständen erfüllt werden.
Patent EA-002067-B1 (EA)
Title: Transdermal therapeutic system
Inventor: DITTGEN MICHAEL
IPC: A61K9/70
Filed: 1998-01-13
Abstract: 1. Transdermal therapeutic system for application to the skin and/or mucosa consisting of at least one active substance in the form of a solid dispersion is combination with at least one destructuring agent and/or at least one structuring agent in a common matrix. 2. Transdermal therapeutic system according to Claim 1, characterized in that the solid dispersion is a molecular dispersion of the active substance in an inert carrier substance. 3. Transdermal therapeutic system according to Claim 2, characterized in that the inert carrier substance is selected from inert carriers known per se for solid dispersions, such as, for example, sucrose, lactose, succinic acid, polyethylene glycols, polyvinyl-pyrrolidone, urea, mannitol, mannitose or mixtures thereof. 4. Transdermal thereapeutic system according to any of Claims 1 to 3, characterized in that the destructuring agent is selected from the group of carboxamides such as urea, nicotinamide, succinamide, methylacetamide, ethylacetamide or mixtures thereof. 5. Transdermal therapeutic system according to Claim 4, characterized is that the relaxation time is more than 120 ms, preferably more than 150 ms. 6. Transdermal therapeutic system according to any of Claims 1 to 5, characterized in that the structuring agent is selected from the group of polyols such as, for example, glycerol, ethylene glycol, propylene glycol, from the group of sugar alcohols such as, for example, sorbitol and/or from the group of sugars such as, for example, sucrose or glucose or mixtures thereof. 7. Transdermal therapeutic system according to Claim 6, characterized in that the relaxation time is less than 119 ms, preferably less than 80 ms. 8. Transdermal therapeutic system according to any of the preceding claims, characterized in that the ratio between destructuring agent and structuring agent is from 10:1 to 1:10. 9. Transdermal therapeutic system according to Claim 8, characterized in that the ratio between destructuring agent and structuring agent is from 2:1 to 1:2. 10. Transdermal therapeutic system according to any of the preceding claims, characterized in that the active substance is selected from hormones, immunomodulators, immunosuppressants. antibiotics, cytostatics, diuretics, gastrointestinal agents, cardiovascular agents and neuropharmaceuticals or mixtures thereof. 11. Transdermal therapeutic system according to Claim 10, characterized in that the active substance is selected from hormones such as testosterone, estradiol, estriol, norethisterone, dienogest or mixtures thereof. 12. Transdermal therapeutic system according to any of Claims 1 to 11, characterized in that the matrix is a sheet-like adhesive piece of material, a plaster, a patch, a gel, an ointment, a cream, an emulsion, an embrocation, a paint or impregnated fabric.
Patent EA-004643-B1 (EA)
Title: Placebo-type compression orthesis
Inventor: GROSJEAN ERIC
IPC: D04B1/26
Filed: 2001-02-27
Abstract: 1. The placebo-type in the form of a medical stocking knitted with a knitting thread (10) having extensible weft inlay (12), wherein the stocking is of the placebo type capable of exerting a compression value at the ankle less than 8 mmHg, preferably less than 5 mmHg. 2. An orthopedic device of claim 1, wherein a thigh/ankle degression ratio of compression is less than 125% and preferably less than 110%. 3. An orthopedic device of claim 1, wherein a thigh/ankle degression ratio of compression is at least 80%. 4. An orthopedic device of claim 1, wherein the weft inlay thread (12) has a linear density ranging between 250 and 600 dtex, preferably between 350 and 500 dtex. 5. An orthopedic device of claim 1, wherein an elastic material proportion is less than 25 %, preferably less than 20 %, of the total yarn count. 6. An orthopedic device of claim 1, wherein the weft inlay thread (12) has elongation capacity ranging between 200 and 350 %, preferably between 200 ad 300 %.
Patent EA-006060-B1 (EA)
Title: Automated system & method for patent drafting & technology assessment
Inventor: GLASGOW JINAN
IPC: G06Q10/10
Filed: 2002-08-30
Abstract: A system for patent application drafting, issued patent and technology assessment (10) includes inputting of technology elements or components (12) into a computer. These components are divided into key components, including the title (14), objective of the invention (16), at least one key component (18). The at least one key component of the invention are those essential for functioning of the invention and those that are necessary for providing patentable distinction over the prior art (20). Also, information relating to background and problems (22) may be input into the system as well. The key component may also have at least one subcomponent (24) that is relationally and hierarchically configured in the diagrammatic representation technology with one key component. Additionally, the subcomponent may have at least one sub-component (26) that is relationally and hierarchically configured in the diagrammatic representation of the invention with the subcomponent and related key component.
Patent EA-010837-B1 (EA)
Title: Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents
Inventor: VOLOSHIN ALEXEI M
IPC: C12P19/34
Filed: 2005-03-21
Abstract: Compositions and methods are provided for the in vitro synthesis of biological molecules in reaction mixtures comprising anti-foam agents. The reaction mix comprising antifoam agent may be a scaled up reaction, e.g. in reaction volume greater than at least about 15 ul. Reactions may be performed in various reactors, as known in the art, which include stirred reactors, bubble-column reactors; and the like.
Patent EA-012760-B1 (EA)
Title: Hoist device
Inventor: ARZBERGER MAXIMILIAN
IPC: B66D1/26
Filed: 2008-01-18
Abstract: The invention relates to a hoist device comprising a first winch with a first winch drum, which rotary driven over a first transmission of a first drive, a second winch with a second winch drum, which rotary driven over a second transmission of a second drive, and a synchronizing device through which rotation of one of the winch drums is synchronized with the rotation of another winch drum. Besides, a balancer shaft with a first synchronous wheel (64) and a second synchronous wheel is provided, the first synchronous wheel is connected over a first rotary connection mechanism with the first drive and the second synchronous wheel over a second rotary connection mechanism with the second drive.
Patent EA-013691-B1 (EA)
Title: Composition with high osmotic activity of antimicrobal, anti-inflammatory and regenerative effect
Inventor: AVERIN KONSTANTIN MIKHAILOVICH
IPC: A61K31/4184
Filed: 2008-01-23
Abstract: The invention relates to pharmacology and cosmetology, in particular, to a group of preparations comprising iodine in an active form and can be applied for treating septic wounds of different etymology and also to preventing growth pathology of skin tissue in effecting different traumatic factors thereon including cosmetologic intervention. The invention is aimed at preparing a composition with high osmotic activity of anti-inflammatory, regenerative and antibacterial effect comprising 1,3-diethylbenzimidazolium triiodide as the anti-inflammatory, regenerative and antibacterial agent, diluent, medicinal low-molecular polyvinylpyrrolidone as a solubilising agent, characterized in that further comprises polyethyleneglycol (macrogol) having own pharmalogic high osmotic activity and dimexide as a solvent and/or glycerol, and/or ethyl alcohol with the following component ratio, wt%:
Patent EA-013854-B1 (EA)
Title: Method and apparatus for manufacturing an elongated product and product
Inventor: JARVENKYLA JYRI
IPC: B21C23/24
Filed: 2007-02-02
Abstract: An elongated product is formed such that first a core is formed, the outer surface of the core being made of plastic. Thereafter, a tubular metal layer is extruded such that the layer is seamless. When the metal layer is extruded, a clearance is allowed between the metal layer and the core. After the metal layer has cooled, the diameter of the metal layer is reduced such that the metal layer contacts the plastic core. Thereafter, the metal is annealed such that the flexibility of the metal layer increases.
Patent EA-015236-B1 (EA)
Title: Method of detecting internal structure of objects and device therefor
Inventor: NAMIOT VLADIMIR ABRAMOVICH
IPC: G01N23/20
Filed: 2009-07-07
Abstract: The invention relates to a method of detecting internal structure of objects and can be used both for objects with periodic structure, including for crystals formed from bioobject, such as, for example, large macromolecules, and for objects with nonperiodic structure. Wherein the time and an amount of calculations required for detecting internal structure can be substantially shortened compared to existing X-ray structural analysis. A device comprises a base, a group of monocrystals is arranged thereon, including three adjoining monocrystals, a screen in one plane with a monocrystal being in the center of said group and consisting of two thin layers weakly absorbing X-rays, between said layers a layer is arranged made of a material strongly absorbing X-rays, and a layer made of a substance emitting in an optical spectrum under the influence of electrons emitted from the absorbing layer, and also two symmetrically-spaced structures arranged relative to the screen, including reference monocrystals inside which there are cavities into which are placed objects to be tested and devices allowing to turn said monocrystals independently relative to three angles in space. Moreover, the base comprises electric motors rotating disks of variable thickness and monocrystals arranged symmetrically to the screen plane. A method is characterized in that two identical copies of object being tested are produced or grown ( in case if the object being tested is of a biological nature or is a monocrystal), and place them in cavities inside the reference monocrystals, after which, using devices rotating the reference monocrystals relative to three angles in space orient them equally. After that, rotating one of crystals exactly at 180° around the axis connecting the centers of the reference monocrystals, electric motors are energized thus driving disks of variable thickness. Then X-ray is emitted to a group of monocrystals consisting of three adjoining monocrystals and, using a video camera, transmit an image information to a computer. After that The X-ray is stopped, again orient the reference crystals equally in space but at another angles than before, and than repeat the procedure anew, starting from the moment of turn of one of monocrystals at 180° around the axis, connecting the centers of the reference monocrystals until the computer has sufficient information for detecting internal structure of the object.
Patent EA-013552-B1 (EA)
Title: Roller pump
Inventor: BAUMANN MANFRED
IPC: F04B43/12
Filed: 2005-05-12
Abstract: The invention relates to a roller pump consisting of a stator with a pump bed formed therein and a rotor for contacting a curved hose placed in the pump bed. According to the invention, the ends of the tube leading out of the pump bed cross. The hose can be fixed in the roller pump by a connector made as an adapter.
Patent EA-026787-B1 (EA)
Title: Nucleic acid construct and use thereof in treating, preventing and inhibiting alzheimer's disease
Inventor: AGADJANYAN MICHAEL G
IPC: A61K39/00
Filed: 2008-08-27
Abstract: The invention relates to a nucleic acid construct encoding a polypeptide that initiates an immune response against Aβ in a human. Provided is a method for the generation of an immune response in an animal and a human, and also a method of treatment of Alzheimer's disease comprising administering and effective amount of the claimed construct. Moreover, provided is a method for the generation of a cellular and humoral immune response in an animal and a human comprising performing preimmunization with the construct of the present invention and enhancing its action by administering the polypeptide encoded with said construct.
Patent EA-021714-B1 (EA)
Title: Apparatus and method for continuous heated water flow for use in hydraulic fracturing
Inventor: HEFLEY RANSOM MARK
IPC: E21B43/26
Filed: 2010-08-17
Abstract: The invention describes a method of hydraulic fracturing of an oil producing formation which includes the provision of a heating apparatus which is transportable and that has a vessel for containing water. The method contemplates heating the water up to a temperature of about 200°F (93.3°C). A water stream of cool or cold water is transmitted from a source to a mixer, the cool water stream being at ambient temperature. The mixer has an inlet that receives cool or cold water from the source and an outlet that enables a discharge of a mix of cool or cold water and the hot water. After mixing in the mixer, the water assumes a temperature that is suitable for mixing with chemicals that are used in the fracturing process, such as a temperature of about 40-120°F (4.4-48.9°C). An outlet discharges a mix of the cool and hot water to surge tanks or to mixing tanks. In the mixing tanks, a proppant and an optional selected chemical or chemicals are added to the water which has been warmed. From the mixing tanks, the water with proppant and optional chemicals is injected into the well for part of the hydraulic fracturing operation. The mixer preferably employs lateral fittings that enable heated water to enter the mixer bore at an acute angle. The mixer can also provide a lateral fitting that exits the mixer bore upstream of the first lateral fitting, the second lateral fitting transmitting water via a conduit such as a hose to the heater.
Patent EA-025719-B1 (EA)
Title: Bypass valve
Inventor: ZHENG DIANHUI
IPC: F16K15/00
Filed: 2012-12-25
Abstract: A bypass valve comprises a valve body (1) which has a gas inlet and a gas outlet, wherein a check valve (4) is provided at the gas outlet. The check valve (4) comprises a check valve body (41), a ventilation plate (42) and a first sealing gasket (43). A first gas passage (411) for gas delivering is provided within the check valve body (41). Ventilation holes (421) are provided on the ventilation plate (42), the ventilation holes being in communication with the gas outlet. The first sealing gasket (43) is provided between the ventilation plate (42) and the check valve body (41), and the first gas passage (411) and the ventilation holes (421) are in selective communication with each other via the first sealing gasket (43). Stepwise annular grooves comprising a first annular groove (14) and a second annular groove (15) are arranged on the valve body (1) at the gas outlet. The ventilation plate (42) is arranged in the first annular groove (14). The check valve body (41) is arranged adjacent to the outer side face of the ventilation plate (42) and fixed to the valve body (1) of the bypass valve by a screw. A sealing ring (5) is arranged in a connection joint between the ventilation plate (42) and the valve body (1) of the bypass valve, and one more sealing ring is arranged in a connection joint between the check valve body (4) and the valve body (1) of the bypass valve. The check valve (4) is provided in the gas outlet in the bypass valve, causing the direction of the gas flow to be unique, overcoming the problem of imprecise concentration of the anaesthetic gas caused by the a gas backflow. Furthermore, the provided bypass valve has more simple structural technology and better gas tightness.
Patent EA-029138-B1 (EA)
Title: Package
Inventor: SINGH SHALENDRA
IPC: B65D85/10
Filed: 2012-06-01
Abstract: Provided is a method for producing a collation package, wherein an arrangement of packages is packed directly in a film. The method comprises: a. providing an arrangement of packages individually wrapped in a filmic material; b. providing a collation film comprising a polyolefinic core layer C, an inner sealing layer A and a polyolefinic outer sealing layer B, the material of the layer A being incompatible for sealing with the filmic material under heat shrinking conditions, and the material of the layer B being compatible for sealing with the layer B and for sealing with the layer A under heat shrinking conditions, wherein the layers A and B are formed of different materials and the layer B comprises a polyolefinic polymer and an antiblock component comprising 1-2% of a silicone compound; c. arranging the packages in an ordered configuration; d. arranging the film such that it surrounds the ordered configuration, although is not in contact with the packages; and e. heat shrinking the film without sealing to the packages.
Patent EA-029256-B1 (EA)
Title: Magnetic field indicator
Inventor: KOZLOWSKI ADAM
IPC: G01R11/24
Filed: 2016-03-14
Abstract: The subject of the present invention is a magnetic field indicator that registers the effect of an external magnetic field on a measuring device; the indicator can be used in electrical meters, water meters or heat meters. The magnetic field indicator comprises a transparent capsule 1 having a bottom 2 made of a ferromagnetic material, the capsule containing a pair of single-domain magnets 3 that have a cylinder shape.
Patent EA-035756-B1 (EA)
Title: Compositions and methods for inhibiting gene expression of hepatitis b virus
Inventor: CHIN DANIEL
IPC: A61K31/713
Filed: 2012-06-28
Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a hepatitis B virus gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by hepatitis B virus infection using said pharmaceutical composition; and methods for inhibiting the expression of a hepatitis B virus gene in a cell.
Patent EA-036517-B1 (EA)
Title: Peptide binding to a molecule of the human major histocompatibility complex class-i; antibody; nucleic acid; expression vector; activated cytotoxic t lymphocyte; host cell and pharmaceutical composition for treating cancer
Inventor: WEINSCHENK TONI
IPC: C07K7/08
Filed: 2014-11-03
Abstract: The invention relates to a peptide binding to a molecule of the human major histocompatibility complex class-I, comprising an amino acid sequence SEQ ID NO: 28 or a sequence which is at least 90% homologous to SEQ ID NO: 28; or a pharmaceutically acceptable salt thereof, wherein said peptide has an overall length of from 9 to 30 amino acids. The invention also relates to an activated cytotoxic T lymphocyte and a method for producing the same, an antibody, a T-cell receptor, nucleic acids, an expression vector, a host cell, a pharmaceutical composition and a kit for treating cancer.
Patent EA-032744-B1 (EA)
Title: Improved mist eliminator operation for quench effluent
Inventor: MCDONEL TIMOTHY ROBERT
IPC: B01D45/08
Filed: 2015-03-26
Abstract: An apparatus comprises a quench vessel configured to provide a quenched gas stream, and a mist eliminator configured to receive the quenched gas stream. The mist eliminator comprises a mist eliminator surface, the mist eliminator surface configured to remove mist from quenched effluent gas. The mist eliminator includes a spray system that includes nozzles configured to spray on the mist eliminator surface. The spray system is effective for reducing formation of a foulant on the mist eliminator surface.